Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Assuta Ashdod Public (Site 0507)

Ashdod, 7747629, IsraelNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Colorectal cancer

Closed trials

Completed
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)
NCT05064059· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Assuta Ashdod Public (Site 0507): trial site – Frontlight Research